HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karl-Friedrich Becker Selected Research

Karl-Friedrich Becker Research Topics

Disease

41Neoplasms (Cancer)
11/2017 - 06/2002
18Carcinoma (Carcinomatosis)
01/2013 - 06/2002
11Breast Neoplasms (Breast Cancer)
05/2015 - 08/2002
9Stomach Neoplasms (Stomach Cancer)
01/2009 - 09/2002
8Neoplasm Metastasis (Metastasis)
01/2013 - 11/2002
5Adenocarcinoma
06/2014 - 05/2004
4Ovarian Neoplasms (Ovarian Cancer)
11/2017 - 12/2010
3Colonic Neoplasms (Colon Cancer)
11/2014 - 09/2004
3Endometrial Neoplasms (Endometrial Cancer)
09/2009 - 12/2007
2Ovarian Epithelial Carcinoma
11/2017 - 01/2013
2Endometrioid Carcinoma
01/2008 - 12/2007
1Cardiovascular Diseases (Cardiovascular Disease)
08/2015
1Metrorrhagia (Spotting)
03/2015
1Lymphatic Metastasis
01/2012
1Prostatic Neoplasms (Prostate Cancer)
12/2011
1Lung Neoplasms (Lung Cancer)
06/2011
1Fibrosis (Cirrhosis)
02/2009
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2007
1HELLP Syndrome
02/2007
1Pre-Eclampsia (Preeclampsia)
02/2007
1Genetic Predisposition to Disease (Genetic Predisposition)
08/2005

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
11/2017 - 08/2002
24Cadherins (E-Cadherin)IBA
01/2013 - 06/2002
16ParaffinIBA
11/2017 - 11/2002
16Formaldehyde (Formol)FDA Link
11/2014 - 11/2002
8ErbB Receptors (EGF Receptor)IBA
01/2013 - 06/2002
5Cell Adhesion MoleculesIBA
10/2004 - 06/2002
4Biomarkers (Surrogate Marker)IBA
11/2017 - 01/2011
4Transcription Factors (Transcription Factor)IBA
09/2009 - 09/2008
4Monoclonal AntibodiesIBA
12/2007 - 09/2003
3Messenger RNA (mRNA)IBA
09/2009 - 11/2002
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2017 - 02/2008
2Growth Factor ReceptorsIBA
11/2017 - 01/2003
2Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2014 - 01/2012
2p38 Mitogen-Activated Protein KinasesIBA
01/2013 - 12/2010
2Plasminogen Activator Inhibitor 1IBA
04/2012 - 01/2011
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2012 - 01/2011
2Hematoxylin (Haematoxylon)IBA
06/2011 - 05/2008
2AntigensIBA
05/2004 - 05/2003
2Pharmaceutical PreparationsIBA
01/2004 - 01/2003
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2017
1PlatinumIBA
11/2017
1Biological ProductsIBA
08/2015
1PhosphoproteinsIBA
05/2015
1Phosphotransferases (Kinase)IBA
05/2015
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
05/2015
1Nucleic AcidsIBA
01/2015
1PlasminogenIBA
01/2012
1glucose-regulated proteinsIBA
01/2012
1Aligeron (AS 2)IBA
01/2012
1Endoplasmic Reticulum Chaperone BiPIBA
01/2012
1Urokinase Plasminogen Activator ReceptorsIBA
01/2012
1Hormones (Hormone)IBA
01/2012
1NitrogenIBA
12/2011
1Estrogen ReceptorsIBA
07/2011
1Progesterone Receptors (Progesterone Receptor)IBA
07/2011
1human ERBB2 proteinIBA
07/2011
1Fixatives (Pickling Agents)IBA
06/2011
1Eosine Yellowish-(YS) (Eosin)IBA
06/2011
1FibrinolysinFDA Link
01/2011
1Epidermal Growth Factor (EGF)IBA
09/2009
1Snail Family Transcription FactorsIBA
05/2009
1CateninsIBA
09/2008
1Tolonium ChlorideFDA Link
05/2008
1GelsIBA
05/2008
1Methyl Green (Green, Light)IBA
05/2008
1Keratin-18 (Keratin 18)IBA
01/2008
1Estrogen Receptor alphaIBA
12/2007
1LectinsIBA
07/2007
1beta CateninIBA
03/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2005
1Integrin alphaVbeta3IBA
03/2005
1Fluorouracil (Carac)FDA LinkGeneric
01/2004
1Etoposide (VP 16)FDA LinkGeneric
01/2004
1Cisplatin (Platino)FDA LinkGeneric
01/2004
1AntibodiesIBA
09/2003
1Bismuth-213IBA
05/2003
1Immunoconjugates (Immunoconjugate)IBA
05/2003
1Terbium-149IBA
05/2003
1RNA (Ribonucleic Acid)IBA
01/2003
1Mutant Proteins (Protein, Mutant)IBA
08/2002
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2002

Therapy/Procedure

10Therapeutics
11/2017 - 01/2003
4Drug Therapy (Chemotherapy)
11/2017 - 12/2010
1Lasers (Laser)
12/2012
1Adjuvant Chemotherapy
01/2011
1Immunotherapy
12/2007
1Radioimmunotherapy
09/2003